Interestingly, previous work revealed that endocytosis of GluA3-containing AMPARs specifically is required for the effects of Amyloid-β, one of the hallmarks of Alzheimer’s disease [15]. Here, GRIA3 is linked to early-onset autosomal dominant Alzheimer disease.